Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2

被引:44
作者
Wang, Xin-Zheng [1 ]
Hang, Ya-Kai [2 ,3 ]
Liu, Jin-Biao [1 ]
Hou, Yong-Qiang [1 ]
Wang, Ning [1 ]
Wang, Ming-Jun [1 ]
机构
[1] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Gen Surg 3, Luoyang City, Henan Province, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
关键词
MicroRNA-375; Papillary thyroid carcinoma; ERBB2; Apoptosis; CERVICAL-CANCER; MIGRATION; INVASION; MIR-375;
D O I
10.1016/j.jphs.2015.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
MicroRNAs (miRs) played important roles in the cell proliferation, apoptosis and other biological processes in cancer. In the present study we found that miR-375 was significantly down-regulated in human papillary thyroid carcinoma (PTC) tissues and cell lines. In this study we try to investigate the biological activity of miR-375 in human PTC cells and try to find the potential target of miR-375. Our study indicated that over-expression of miR-375 could inhibit the PTC cells proliferation and this inhibition was caused by the induction of cell apoptosis. In vivo animal study indicated that over-expression of miR-375 could significantly decrease the migration and invasion of human PTC cell in vivo. These results exhibit over-expression of miR-375 in human PTC cells could inhibit the process of human PTC. Further study demonstrated ERBB2 was a direct target of miR-375, over-expression of miR-375 decrease the both mRNA and protein expression of ERBB2 in human PTC cells. These data indicate miR-375 play important roles in the process and development of human PTC. These finds suggested that appropriate application of miR-375 regulation might be a new sight for the treatment of human PTC in the future. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 27 条
  • [1] Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
    Bang, Yung-Jue
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (08) : 637 - 648
  • [2] Function of microRNA-375 and microRNA-124a in pancreas and brain
    Baroukh, Nadine N.
    Van Obberghen, Emmanuel
    [J]. FEBS JOURNAL, 2009, 276 (22) : 6509 - 6521
  • [3] Thyroid Cancer
    Carling, Tobias
    Udelsman, Robert
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 : 125 - 137
  • [4] Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis
    Chan, Christine M.
    Jing, Xia
    Pike, Laura A.
    Zhou, Qiong
    Lim, Dong-Jun
    Sams, Sharon B.
    Lund, Gregory S.
    Sharma, Vibha
    Haugen, Bryan R.
    Schweppe, Rebecca E.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (13) : 3580 - 3591
  • [5] Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps
    Chi, Sung Wook
    Zang, Julie B.
    Mele, Aldo
    Darnell, Robert B.
    [J]. NATURE, 2009, 460 (7254) : 479 - 486
  • [6] MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2
    Ding, Ling
    Xu, Yanjun
    Zhang, Wei
    Deng, Yujie
    Si, Misi
    Du, Ying
    Yao, Haomi
    Liu, Xuyan
    Ke, Yuehai
    Si, Jianmin
    Zhou, Tianhua
    [J]. CELL RESEARCH, 2010, 20 (07) : 784 - 793
  • [7] Small RNA Regulation of Reproductive Function
    Hale, Benjamin J.
    Yang, Cai-Xia
    Ross, Jason W.
    [J]. MOLECULAR REPRODUCTION AND DEVELOPMENT, 2014, 81 (02) : 148 - 159
  • [8] The role of microRNA genes in papillary thyroid carcinoma
    He, HL
    Jazdzewski, K
    Li, W
    Liyanarachchi, S
    Nagy, R
    Volinia, S
    Calin, GA
    Liu, CG
    Franssila, K
    Suster, S
    Kloos, RT
    Croce, CM
    de la Chapelle, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (52) : 19075 - 19080
  • [9] MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts
    Hodge, L. S.
    Elsawa, S. F.
    Grote, D. M.
    Price-Troska, T. L.
    Asmann, Y. W.
    Fonseca, R.
    Gertz, M. A.
    Witzig, T. E.
    Novak, A. J.
    Ansell, S. M.
    [J]. BLOOD CANCER JOURNAL, 2011, 1 : e24 - e24
  • [10] MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
    Iorio, Marilena V.
    Croce, Carlo M.
    [J]. EMBO MOLECULAR MEDICINE, 2012, 4 (03) : 143 - 159